| Literature DB >> 32429286 |
Diana Chapeton-Montes1, Lucile Plourde2, Cecile Deneve1, Dominique Garnier2, Fabien Barbirato2, Vincent Colombié2, Sandy Demay2, Georges Haustant1, Olivier Gorgette3, Christine Schmitt3, Catherine Thouvenot3, Holger Brüggemann4, Michel R Popoff1.
Abstract
Clostridium tetani produces a potent neurotoxin, the tetanus toxin (TeNT), which is responsible for an often-fatal neurological disease (tetanus) characterized by spastic paralysis. Prevention is efficiently acquired by vaccination with the TeNT toxoid, which is obtained by C. tetani fermentation and subsequent purification and chemical inactivation. C. tetani synthesizes TeNT in a regulated manner. Indeed, the TeNT gene (tent) is mainly expressed in the late exponential and early stationary growth phases. The gene tetR (tetanus regulatory gene), located immediately upstream of tent, encodes an alternative sigma factor which was previously identified as a positive regulator of tent. In addition, the genome of C. tetani encodes more than 127 putative regulators, including 30 two-component systems (TCSs). Here, we investigated the impact of 12 regulators on TeNT synthesis which were selected based on their homology with related regulatory elements involved in toxin production in other clostridial species. Among nine TCSs tested, three of them impact TeNT production, including two positive regulators that indirectly stimulate tent and tetR transcription. One negative regulator was identified that interacts with both tent and tetR promoters. Two other TCSs showed a moderate effect: one binds to the tent promoter and weakly increases the extracellular TeNT level, and another one has a weak inverse effect. In addition, CodY (control of dciA (decoyinine induced operon) Y) but not Spo0A (sporulation stage 0) or the DNA repair protein Mfd (mutation frequency decline) positively controls TeNT synthesis by interacting with the tent promoter. Moreover, we found that inorganic phosphate and carbonate are among the environmental factors that control TeNT production. Our data show that TeNT synthesis is under the control of a complex network of regulators that are largely distinct from those involved in the control of toxin production in Clostridium botulinum or Clostridium difficile.Entities:
Keywords: Clostridium botulinum; Clostridium tetani; gene transcription; tetanus toxin; two-component system
Mesh:
Substances:
Year: 2020 PMID: 32429286 PMCID: PMC7290440 DOI: 10.3390/toxins12050328
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Two component system (TCS) genes encoded in the genome of C. tetani E88 and their homology with regulatory genes in other clostridia. The recombinant RNA antisense plasmids targeting TCS genes are indicated in column 1. Genetic environment indicates functional genes in close proximity of TCS in C. tetani E88.
| Recombinant Antisense mRNA Plasmid | Gene Bank Accession Number | Other Gene Name | Role | Familly (RR) | Genetic Environment | Homology | Homologs (RR) in Other Clostridia (Protein Identity > 60%) | Homolog TCS in | Homolog TCS in | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Old Locus Tag | Locus Tag | Homolog System (RR/SHK) | Protein Identity (RR) | Regulation of Botulism Neurotoxin | Homolog System (RR/SHK) | Protein Identity/Positive | |||||||
|
| |||||||||||||
| CTC_00189 | CTC_RS00820 | RR | OmpR | Periplasmic endopeptidase | ResD, respiration control |
| CLC_3521/CLC_3520 | 81% | None | CBO3543 | 81/87 | ||
| CTC_00191 | CTC_RS00825 | SHK | CBO3542 | 67/73 | |||||||||
| CTC_00392 | CTC_RS01985 | RR | OmpR | ABC Transporter | BacS/BacR regulation of resistance to bacitracin |
| CLC_0331/CLC_0332 | 90% | None | CBO0272 | 90/92 | ||
| CTC_00393 | CTC_RS01990 | SHK | CBO0273 | 86/89 | |||||||||
| CTC_00411 | CTC_RS02080 | phoP | RR | OmpR | hydroxylamne reductase | VirI/VirJ regulation of toxin synthesis |
| CLC_0661/CLC_0663 | 65% | Positive | CBO0607 | 64/72 | |
| p1308 | CTC_00412 | CTC_RS02085 | phoR | SHK | CBO0608 | 46/55 | |||||||
| CTC_00455 | CTC_RS02330 | RR | phosphomannomutase/ phosphoglucomutase | putative rRNA methylase |
| CLC_0413 | 55% | unknown | CBO0355 | 54/59 | |||
| CTC_00456 | CTC_RS14405 | SHK | no | ||||||||||
| CTC_00597 | CTC_RS02990 | RR | OmpR | Glycerine-deshydrogenase | BacR regulation of resistance to bacitracin |
| CLC_2212/CLC_2211 | 45% | None | several | 45/66 | ||
| CTC_00598 | CTC_RS02995 | SHK | no | ||||||||||
| CTC_00628 | CTC_RS03125 | spaR | RR | OmpR | ABC Transporter SpaEFG: export subtiline | SpaR/SpaK regulation of resistance to subtilin |
| CLC_1615/CLC_1616 | 65% | unknown | CBO1585 | 65/69 | |
| CTC_00629 | CTC_RS03130 | spaK | SHK | CBO1586 | 37/43 | ||||||||
| CTC_00805 | CTC_RS04010 | RR | OmpR | Protein transport | VanR/VanS regulation of resistance to vancomycin |
| CLC_0423/CLC_0424 | 76% | None | CBO0365 | 78/82 | ||
| CTC_00806 | CTC_RS04015 | SHK | CBO0366 | 44/50 | |||||||||
| CTC_00848 | CTC_RS04235 | RR | OmpR | Heat shock protein | GtcS/GtcR regulation of antibiotic synthesis (gramicidin) |
| CLC_1640/CLC_1639 | 48% | None | several | 47/55 | ||
| CTC_00849 | CTC_RS04240 | SHK | no | ||||||||||
| CTC_00872 | CTC_RS04365 | RR | OmpR | Efflux-ATPase Copper | Arc, regulation of aerobic/anaerobic respiration |
| CLC_1088/CLC_1089 | 68% | None | CBO1035 | 66/71 | ||
| CTC_00873 | CTC_RS04370 | SHK | CBO1036 | 55/63 | |||||||||
| CTC_00924 | CTC_RS04645 | SHK | PucR | Zn-dependent protease | regulation of purine catabolism, methyl-accepting chemotaxis protein | No | CBO1773 | 43/50 | |||||
| CTC_00925 | CTC_RS04650 | RR | no | ||||||||||
| p1309 | CTC_00934 | CTC_RS04705 | SHK | AraC | amihydrolase; Pyruvate formate lyase | LytS, autolysis regulation |
| CLC_1627 | 41% | unknown | no | ||
| CTC_00935 | CTC_RS04710 | RR | no | ||||||||||
| CTC_00949 | CTC_RS04780 | virS | SHK | LytR/AlgR | transcriptional regulator, merR family; putative methyl-accepting chemotaxis protein | virulence regulation |
| CLC_1105/CLC_1104 | 35% | None | no | ||
| p1310 | CTC_00950 | CTC_RS04785 | virR | RR | CBO1053 | 35/54 | |||||||
| CTC_01130 | CTC_RS05745 | RR | OmpR | ABC Transporteur: phosphates | PhoP/PhoR, regulation of phosphate uptake |
| CLC_2386/CLC_2385 | 73% | None | CBO2527 | 73/87 | ||
| p1311 | CTC_01131 | CTC_RS05750 | phoR | SHK | CBO2526 | 52/75 | |||||||
| p1312 | CTC_01211 | CTC_RS06180 | tlpA | SHK | LysR | anaerobic sulfite reductase | LytR, autolysis regulation, methyl-accepting chemotaxis protein tlpA |
| CLC_3570 | 35% | unknown | CBO2828 | 36/61 |
| CTC_01212 | CTC_RS06185 | RR | several | 35/57 | |||||||||
| CTC_01420 | CTC_RS07310 | resE | SHK | OmpR | ABC Transporter | YycG/YycF, regulation of cell division |
| CLC_0842/CLC_0843 CB00786/CB00787 * | 58% | None Negative | CBO0787 | 47/65 | |
| p1419 | CTC_01421 | CTC_RS07315 | RR | CBO0786 | 58/76 | ||||||||
| CTC_01481 | CTC_RS07700 | SHK | OmpR | Conserved proteins with transmembrane helices and 4Fe4S motif | FeuQ/FeuP, regulation of iron acquisition |
| CLC_3521/CLC_3520 | 43% | None | no | |||
| CT_01482 | CTC_RS07705 | RR | several | 43/60 | |||||||||
| CTC_01490 | CTC_RS07755 | RR | OmpR | Heat shock protein HtpG (chaperonne); Membrane protein | unknown |
| CLC_0423/CLC_0424 | 44% | None | several | 44/64 | ||
| CTC_01491 | CTC_RS07760 | SHK | no | ||||||||||
| CTC_01523 | CTC_RS07895 | RR | NarL | Fumarate-reductase soluble flavoprotein | DcuR, regulation of fumarate anaerobic respiration through C4-dicarboxylates |
| CLC_0307/CLC_0306 | 48% | None | CBO0249 | 48/69 | ||
| CTC_01524 | CTC_RS07900 | dpiB | SHK | CBO0248 | 41/60 | ||||||||
| CTC_01804 | CTC_RS09305 | SHK | OmpR | ABC Transporter | BacS/BacR, AB-Bacitracine synthesis and regulation |
| CLC_2212/CLC_2211 | 56% | None | CBO2284 | 47/72 | ||
| CTC_01805 | CTC_RS09310 | RR | CBO2285 | 56/79 | |||||||||
| CTC_01818 | CTC_RS09380 | resE | SHK | OmpR | ABC Transporter; RNA polymerase sigma factor | unknown |
| CLC_0842/CLC_0843 CB00786/CB00787* | 51% | None Negative | CBO0787 | 38/63 | |
| CTC_01819 | CTC_RS09385 | RR | CBO0786 | 51/71 | |||||||||
| CTC_01848 | CTC_RS14320 | yesM | SHK | NarL/FixJ | Fumarate-reductase | unknown |
| CLC_2236/CLC_2235 | 26% | None | no | ||
| CTC_01849 | CTC_RS09510 | RR | no | ||||||||||
| CTC_01857 | CTC_RS09550 | SHK | XRE | Helicase, oleate hydratase | SinR regulation of entry in stationary phase, to nutrient depletion; Spo0A repressor |
| No | CBO0693 | 48/70 | ||||
| CTC_01858 | CTC_RS09555 | sinR | RR | no | |||||||||
| CTC_01905 | CTC_RS09790 | SHK | OmpR | ABC Transporter | BacR; VanR (synthèse et régulation AB) |
| CLC_0423/CLC_0424 | 45% | None | no | |||
| CTC_01906 | CTC_RS09795 | RR | CBO0365 | 45/66 | |||||||||
| CTC_01918 | CTC_RS09860 | resE | SHK | OmpR | ABC Transporter | BacR; VanR (synthèse et régulation AB) |
| CLC_0842/CLC_0843 CB00786/CB00787* | 42% | None Negative | CBO0787 | 32/53 | |
| CTC_01919 | CTC_RS09865 | RR | CBO0786 | 42/60 | |||||||||
| p1313 | CTC_01951 | CTC_RS10030 | phoR | SHK | OmpR | Heavy metal translocating P-type aTPase | PhoP/PhoR regulation of phosphate uptake |
| CLC_0410/CLC_0411 | 68% | Positive | CBO0353 | 57/78 |
| CTC_01953 | CTC_RS10035 | phoP | RR | CBO0352 | 68/86 | ||||||||
| CTC_01978 | CTC_RS10150 | SHK | LytR/AlgR | carbon starvation protein A CstA | LytS/LytR autolysis regulation |
| CLC_3250/CLC_3251 | 55% | None | CBO3309 | 51/71 | ||
| p1314 | CTC_01979 | CTC_RS10155 | RR | CBO3308 | 55/78 | ||||||||
| CTC_02155 | CTC_RS11115 | SHK | OmpR | DNA mismatch repair protein hexA | VanS/VanR regulation of resistance to glycopeptides |
| CLC_1640/CLC_1639 | 77% | None | CBO1612 | 48/68 | ||
| CTC_02156 | CTC_RS11120 | RR | CBO1613 | 77/86 | |||||||||
| CTC_02178 | CTC_RS11240 | SHK | Fis | ethanolamine utilization protein EutA, EutP | EutS/EutR regulation of éthanolamine utilization |
| No | no | |||||
| CTC_02179 | CTC_RS11245 | RR | no | ||||||||||
| CTC_02322 | CTC_RS11915 | RR | Fis | sodium/glutamate symport carrier protein; V-Typ-ATPase-protein | AtoS/AtoC regulation of acetoacetate metabolism |
| CLC_1882 | 40% | unknown | several | 46/63 | ||
| CTC_02323 | CTC_RS11920 | SHK | no | ||||||||||
|
| |||||||||||||
| p1307 | CTC_p22 | CTC_RS13810 | SHK | OmpR | ATP-binding protein | unknown |
| CLC_1431/CLC_1432 | 56% | None | CBO1395 | 39/60 | |
| CTC_p21 | CTC_RS13805 | RR | CBO1394 | 56/74 | |||||||||
RR, Response Regulator; SHK, Sensor Histidine Kinase, * 100% homology with TCSs of C. botulinum ATCC3502.
CN655 anti-sense strains, and primers used for the construction of recombinant plasmids generating antisense mRNA. The PCR products from CN655 genome DNA contain a 3’NcoI site and a 5’PstI site and were cloned into pMRP306, a derivative of pAT19 containing the promoter of the iota toxin gene, the cloning sites NcoI-PstI and the 3’part of the iota toxin gene [14]. The resultant antisense RNA plasmids were transformed into CN655 by electroporation. SHK: Sensor Histidine Kinase, RR: Response regulator.
| Isogenic Antisense Strains | Target Gene | S/R | Primer | Nucleotide Sequence (5′--> 3) | Product Length (bp) |
|---|---|---|---|---|---|
| CN655/1307 | CTC_p22 | S | P2020-F | CCGCTGCAGGATAATTTGGGAATGATTATTTTA | 228 |
| P2021-R | GGCCATGGTTAACATATCGTCCATACTC | ||||
| CN655/1308 | CTC_00412 | S | P2022-F | CCGCTGCAGGAGGTGATTGAAAAATAG | 208 |
| P2023-R | GGCCATGGTAAATCTAACATAGTAAATTTATAC | ||||
| CN655/1310 | CTC_00950 | R | P2024-F | CCGCTGCAGGGAGGGTTAAATTATGTATAATG | 236 |
| P2025-R | GGCCATGGGCTACTTCTATACCATTTATTTC | ||||
| CN655/1309 | CTC_00934 | S | P2026-F | CCGCTGCAGCAGGGGGTATTTTTGTGTTAAATAATAGG | 236 |
| P2027-R | GGCCATGGCATTGGCATCGCAACATATGCG | ||||
| CN655/1312 | CTC_01211 | S | P2028-F | CCGCTGCAGGGGGAGACAGTGGTGAAGTTGCG | 223 |
| P2029-R | GGCCATGGGGTTAAAAAATTTTCTTTTATATTTC | ||||
| CN655/1314 | CTC_01979 | R | P2030-F | CCGCTGCAGGAGATGAATTTATGAACAAAAT | 231 |
| P2031-R | GGCCATGGGCTAATTCCATGCCATTTTTAG | ||||
| CN655/1311 | CTC_01131 | S | P2032-F | CCGCTGCAGGGTGGTAAAATGAAAAAAAG | 245 |
| P2033-R | GGCCATGGCCTTATATCACTATCATTA | ||||
| CN655/1313 | CTC_01951 | S | P2034-F | CCGCTGCAGGGAAGGTAGAAAATGAAAAGTATAAAG | 243 |
| P2035-R | GGCCATGGCCACATTATCCATTATATTTTCTTC | ||||
| CN655/1419 | CTC_01421 | R | P2291-F | CCGCTGCAGGGGAGATTTTGTGAACAACATATT | 242 |
| P2292-R | GGCCATGGTCTGATGCCTTTCTTATTTCTTTAC | ||||
| CN655/1418 | CTC_01260 | CodY | P2289-F | CCGCTGCAGGAGGAGTTACAAATGTCATCATTATTA | 232 |
| P2290-R | GGCCATGGACTACCTTGTCTCTTACTGTCTG | ||||
| CN655/1472 | CTC_00222 | Spo0 | P2361-F | CCGCTGCAGGGAGGTATAAAATATATGATA | 225 |
| P2362-R | GGCCATGGTTATTACACTCTTTAAAGGTGAA | ||||
| CN655/1480 | CTC_00194 | mfd | P2359-F | CCGCTGCAGGAGGTGAATTTTATTATGAGAT | 236 |
| P2360-R | GGCCATGGAATATTTTTTGCTTCTATATCG |
Figure 1Growth kinetics of C. tetani strain CN655/pAT18 (empty vector) and CN655 antisense strains. (A) CN655/p1308, CN655/p1310, CN655/p1311, CN655/p1419, CN655/p1418, CN655/1480 and CN655/p1472 showed a similar kinetics compared to CN655/pAT18 strain. (B) CN655/p1307, CN655/p1309, CN655/p1312, CN655/p1313 and CN655/p1314 displayed a more abundant growth than CN655/pAT18 in the early stationary phase (12–48 h). Data are mean values ± SEM of at least three independent cultures.
Figure 2Extracellular tetanus toxin (TeNT) produced by C. tetani CN655/pAT18 (empty vector) and CN655 antisense strains. (A) Extracellular toxin was reduced in the culture supernatant of CN655/p1307, CN655/p1310, CN655/p1314 and CN655/p1418. (B) CN655/p1311 and CN655/p1419 showed elevated extracellular toxin kinetics compared to control strain CN655/pAT18. Statistical significance of differences between control and anti-sense strains is indicated with p-values (*, p < 0.05; **, p < 0.01; ***, p < 0.001). Data are mean values ± SEM of at least three independent cultures.
Figure 3Total tetanus toxin (TeNT) produced by C. tetani CN655/pAT18 (empty vector) and CN655 antisense strains. (A) Total tetanus toxin production was reduced in CN655/p1307, CN655/p1314 and CN655/p1418. (B) CN655/p1419 showed elevated total toxin kinetics compared to control strain CN655/pAT18. Three independent experiments have been done. Statistical significance of differences between control strain and anti-sense strains is indicated with p-values (*, p < 0.05; **, p < 0.01).
Figure 4Expression of (A) tent and (B) tetR in CN655/pAT 18 and CN655 antisense strains. (A) The expression of tent was repressed in CN655/p1307, CN655/p1310, CN655/p1314 and CN655/p1418 compared to the control strain CN655/pAT18. For strains CN655/p1311 and CN655/p1419, an increased tent expression was observed. (B) The expression of tetR was repressed in CN655/p1307, CN655/p1310, CN655/p1312, CN655/p1313, CN655/p1314, CN655/p1419 and CN655/p1418. Strain CN655/p1311 showed an increase in tetR expression compared to the control strain CN655/pAT18. Target gene expression was normalized to rpoB and gyrA. Three independent experiments have been done. Statistical significance of differences between control and the anti-sense strains is indicated with p-values (*, p < 0.05; **, p < 0.01).
Figure 5Electrophoretic mobility shift assay (EMSA) showing regulatory protein binding to tent (A) and tetR (B) promoters. Biotin-labeled DNA probes corresponding to the promoter regions of tent (P) and tetR (P) were incubated with 5 μM of the recombinant proteins CTC_RS13805, CTC_RS10155, CTC_RS07315, CTC_RS04710, CTC_RS05745, CTC_RS04785, CodY and TetR. The specific binding of recombinant proteins to promoter probes resulted in an observable mobility shift when compared to the P and P alone. Competition assays were performed with a 300-fold excess of unlabeled probe. Specificity of binding to P was confirmed for CTC_RS07315, CTC_RS04785, CodY and TetR. CTC_RS07315 was the only protein showing specific binding to P. Addition of recombinant proteins, unlabeled promoter probe as cold competitor and labeled promoter probes are indicated. Representative experiments out of three are shown.
Figure 6Effect of inorganic phosphate on tetanus toxin (TeNT) production, and tent/tetR expression. (A) Growth kinetics of CN655 in TGY supplemented with various concentrations of inorganic phosphate. (B) Extracellular TeNT levels. (C) Total TeNT levels. (D) Expression of tent and (E) tetR. Data are mean values ± SEM of at least three independent cultures. *, p < 0.05; **, p < 0.01.
Figure 7Effects of sodium carbonate and inorganic phosphate on extracellular tetanus toxin (TeNT). C. tetani CN655 was grown in TGY supplemented with either 50 or 100 mM Na2CO3, 40 mM Pi, or 100 mM Na2CO3 and 40 mM Pi. Extracellular toxin levels were increased in TGY medium supplemented with 40 mM Pi or 100 mM Na2CO3. The addition of both Pi and Na2CO3 did not result in a synergistic effect on TeNT production. Data are mean values ± SEM of at least three independent assays. **, p < 0.05.
Figure 8Ultrastructural morphology of CN655 and CN655/p1311. Bacteria from 18 h TGY culture were processed for transmission electron microscopy and scanning electron microscopy (SEM). CN655 showed well-delineated bacterial wall layers, whereas the bacterial wall of CN655/p1311 was disorganized with diffuse and enlarged wall layers. CN655/p1311 showed more abundant blebbings on the bacterial surface. About 100 bacterial cells were observed for each preparation.
Figure 9Schematic summary of the regulators of tetanus toxin (TeNT) synthesis of this study. Two two-component systems (TCSs) (RS13815 and RS10155) as well as CodY are positive regulators. They activate the transcription of tetR and tent, only CodY acts directly by interacting with the promoter of tent (P). In addition, the TCS RS04785 increases the extracellular TeNT level without or only weakly affecting the total synthesis by interacting with P. One TCS (RS07315) is a negative regulator that interacts with (P) and (P). The TCS RS05750 has a moderate negative effect by weakly and indirectly decreasing tent and tetR transcription. Inorganic phosphate (Pi) and carbonate are environmental factors that influence TeNT synthesis through the TCS pathway and/or through the general metabolism.
Primers used for qRT-PCR, protein expression and promoter regions of tent and tetR for EMSA experiments.
| Target Gene | Primer | Nucleotide Sequence (5′-->3) | Product Length (bp) |
|---|---|---|---|
|
| |||
|
| P1714-F | CCAAGGTGCACAAGGAATTT | 146 |
| P1715-R | CAATGTTTAATGCGGGTCCT | ||
|
| P1726-F | GTTGCTCAAATTATTTAAACTTCGAA | 115 |
| P1727-R | GCTATATCACATTCTTTCATATCTTCAAA | ||
|
| P2142-F | TTGAAGAATGTAAAGAGAGAGATGCTAC | 118 |
| P2143-R | GGGAAGTCACCCATAAAGACA | ||
|
| P2146-F | AAGATGATGTAGCAGTAAGTATGGA | 98 |
| P2147-R | CTCTGAAGCCAATGTCCTTTT | ||
|
| |||
| CTC_p21 | P2349-F | CGCCGCGGATCCATGTATAAGATATTGATTGTTGAA | 711 |
| P2350-R | CCGCCGGAATTCTTACACCTGAAATAAACGATAGCC | ||
| CTC_01979 | P2351-F | CGCCGCGGATCCATGAACAAAATAAATTGTGTAATAATA | 792 |
| P2352-R | CCGCCGGAATTCTTAAAAATCTAATATGTCCTTTAAGTG | ||
| CTC_01421 | P2353-F | CGCCGCGGATCCGTGAACAACATATTGTTAGTTGAA | 717 |
| P2354-R | CCGCCGGAATTCCTATTTATTAATTTCGTAGTTCCACCT | ||
| codY | P2355-F | CGCGGATCCATGTCATCATTATTAGAGAAG | 801 |
| P2356-R | CCGCCGGAATTCTTACTTAATTTTTTTCAATTCCTC | ||
| CTC_00935 | P2357-F | CGCGGATCCGTGTGTAGAGTAGTGCTT | 759 |
| P2358-R | CCGCCGGAATTCTTATACTTTTTTATTATTCAC | ||
|
| |||
| P | P2365-F | (5’-end labelled biotin) GGTGGCTCCATCATAATAATTGTAT | 359 |
| P2366-R | (5’-end labelled biotin) GGTTTTAGCATTAAAAAAATTAGAACCTA | ||
| P | P2363-F | (5’-end labelled biotin) CAGTATTTTTGAAATGTATAATAATTACTTC | 316 |
| P2364-R | (5’-end labelled biotin) CGGTTCTCTTAATTTAGTAATATCAATAT | ||
F, forward; R, reverse.